Imatinib inhibits oral squamous cell carcinoma by suppressing the PI3K/AKT/mTOR signaling pathway.
Ma L, Huang K, Zhang H, Kim E, Kim H, Liu Z, Kim CY, Park K, Raza MA, Kim K, Yi J, Sung Y, Ryoo ZY, Kim YG, Kim MO.
Ma L, et al. Among authors: ryoo zy.
J Cancer. 2024 Jan 1;15(3):659-670. doi: 10.7150/jca.88555. eCollection 2024.
J Cancer. 2024.
PMID: 38213733
Free PMC article.